Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Exelixis reported $379.96M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 172.05M 10.51M
Agios Pharmaceuticals AGIO:US USD 96.22M 120.59M
Akebia Therapeutics AKBA:US USD 65.06M 3.53M
Amgen AMGN:US USD 4.07B 538M
AstraZeneca AZN:LN USD 8.33B 1.78B
Bayer BAYN:GR EUR 11.42B 848M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Bluebird Bio BLUE:US USD -6056000 19.32M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Cytokinetics CYTK:US USD 129.09M 99K
Eisai 4523:JP JPY 171.99B 7.01B
Eli Lilly LLY:US USD 5.47B 600K
Esperion Therapeutics ESPR:US USD 72.93M 11.6M
Exelixis EXEL:US USD 379.96M 92.04M
Genmab GEN:DC DKK 2.42B 145M
Glaxosmithkline GSK:US GBP 4.87B 640M
Immunogen IMGN:US USD 92.26M 8.46M
Incyte Corp INCY:US USD 783.9M 72.7M
Ionis Pharmaceuticals IONS:US USD 244.67M 115.24M
MacroGenics MGNX:US USD 62.92M 1.81M
Merck & Co MRK:US USD 10.76B 371M
Mirati Therapeutics MRTX:US USD 200.99M 11.67M
Moderna Inc MRNA:US USD 2.23B 1.28B
Nektar Therapeutics NKTR:US USD 156.3M 81.81M
Neurocrine Biosciences NBIX:US USD 534.6M 226M
Novartis NOVN:VX USD 10.35B 700M
Pfizer PFE:US USD 11.5B 7.63B
Puma Biotechnology PBYI:US USD 48.41M 19.61M
Seattle Genetics SGEN:US USD 704.23M 22.08M
Takeda 4502:JP JPY 867.59B 81.97B
Ultragenyx Pharmaceutical RARE:US USD 254.6M 5.62M
Xencor XNCR:US USD 78.33M 14.02M